Cargando…
Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common neoplasm and the major cause of cancer-associated death worldwide. The high mortality rate of HCC is mainly attributed to its widespread prevalence and the lack of effective treatment. Immunotherapy as a promising, innovative approach has revolutioni...
Autores principales: | Li, Rui, Jin, Chen, Zhao, Weiheng, Liang, Rui, Xiong, Huihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639314/ https://www.ncbi.nlm.nih.gov/pubmed/36344926 http://dx.doi.org/10.1186/s12876-022-02540-2 |
Ejemplares similares
-
Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma
por: Li, Rui, et al.
Publicado: (2022) -
The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma
por: Yang, Shiming, et al.
Publicado: (2021) -
Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma
por: Chen, Rui, et al.
Publicado: (2021) -
Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Bai, Yang, et al.
Publicado: (2021) -
Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma
por: Hong, Weifeng, et al.
Publicado: (2020)